ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,242.72
-0.09%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tanox (MM) (TNOX)

  7. Tanox (MM) (TNOX) Noticias

TNOX

Tanox (TNOX)

Tanox (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TNOX
FechaHoraFuenteTítuloSímboloCompañía
02/08/200716:30PR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Respiratory/Pulmonary IndexNASDAQ:TNOXTanox (MM)
09/05/200716:02PR Newswire (US)Tanox Reports 2007 First Quarter ResultsNASDAQ:TNOXTanox (MM)
15/03/200716:53PR Newswire (US)Tanox Reports Fourth Quarter and Full Year 2006 ResultsNASDAQ:TNOXTanox (MM)
29/01/200707:36PR Newswire (US)Genentech and Tanox Receive 'Second Request' from the Federal Trade CommissionNASDAQ:TNOXTanox (MM)
15/01/200713:43PR Newswire (US)Tanox, Inc. Stockholders Approve Merger With Genentech, Inc.NASDAQ:TNOXTanox (MM)
09/11/200616:50PR Newswire (US)Genentech Announces Agreement to Acquire Tanox for $20 Per ShareNASDAQ:TNOXTanox (MM)
02/11/200605:30PR Newswire (US)Tanox Reports 2006 Third Quarter ResultsNASDAQ:TNOXTanox (MM)
25/10/200606:00PR Newswire (US)Tanox Initiates Phase 1 Clinical Trial Evaluating TNX-650 for Treatment of AsthmaNASDAQ:TNOXTanox (MM)
24/10/200617:10PR Newswire (US)Tanox to Report Third Quarter 2006 Financial Results, Host Conference Call for Investors Nov. 2NASDAQ:TNOXTanox (MM)
14/09/200614:03PR Newswire (US)Tanox to Present at UBS Global Life Sciences ConferenceNASDAQ:TNOXTanox (MM)
31/08/200607:00PR Newswire (US)Tanox to Present at the Bear Stearns Healthcare ConferenceNASDAQ:TNOXTanox (MM)
17/08/200613:00PR Newswire (US)New Data Confirm Durable Response of TNX-355 Regimens Through 48 Weeks in Treatment-Experienced HIV PatientsNASDAQ:TNOXTanox (MM)
08/08/200605:30PR Newswire (US)Tanox Reports 2006 Second Quarter ResultsNASDAQ:TNOXTanox (MM)
03/08/200617:45PR Newswire (US)Tanox Conducts Meeting With Food and Drug Administration Regarding Its HIV/AIDS Antibody, TNX-355NASDAQ:TNOXTanox (MM)
18/07/200608:00PR Newswire (US)Tanox to Report Second Quarter 2006 Financial Results, Host Conference Call for Investors Aug. 8NASDAQ:TNOXTanox (MM)
31/05/200618:21PR Newswire (US)Results of TNX-355 Combination Study Published in Antimicrobial Agents and ChemotherapyNASDAQ:TNOXTanox (MM)
23/05/200605:00PR Newswire (US)First Patient Dosed in Phase 1 Trial of Tanox's TNX-650NASDAQ:TNOXTanox (MM)
02/05/200605:00PR Newswire (US)Tanox Reports 2006 First Quarter ResultsNASDAQ:TNOXTanox (MM)
02/05/200604:00PR Newswire (US)Tanox Reports 48-Week Results From TNX-355 Phase 2 Clinical TrialNASDAQ:TNOXTanox (MM)
17/04/200615:30PR Newswire (US)Tanox to Present at Two Investor Conferences in MayNASDAQ:TNOXTanox (MM)
10/04/200612:00PR Newswire (US)Tanox to Report First Quarter 2006 Financial Results, Host Conference Call for Investors May 2NASDAQ:TNOXTanox (MM)
28/02/200605:30PR Newswire (US)Tanox Reports Fourth Quarter and Full Year 2005 ResultsNASDAQ:TNOXTanox (MM)
09/02/200613:00PR Newswire (US)New Research Reaffirms Tropism Independence of TNX-355; Data for Tanox's Novel HIV Viral Entry Inhibitor Presented at 2006 CROINASDAQ:TNOXTanox (MM)
08/02/200621:30PR Newswire (US)Tanox to Report 2005 Fourth Quarter and Full Year Results Feb. 28NASDAQ:TNOXTanox (MM)
03/02/200609:34PR Newswire (US)Tanox to Present at Two Investor Conferences in FebruaryNASDAQ:TNOXTanox (MM)
23/01/200606:00PR Newswire (US)Tanox Receives Multimillion Xolair(R) Milestone PaymentNASDAQ:TNOXTanox (MM)
04/01/200612:29PR Newswire (US)Tanox to Present at JP Morgan Healthcare ConferenceNASDAQ:TNOXTanox (MM)
20/12/200513:14PR Newswire (US)Tanox Submits Investigational New Drug Application for TNX-650 for Treatment of Hodgkin's LymphomaNASDAQ:TNOXTanox (MM)
17/12/200512:30PR Newswire (US)Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry InhibitorNASDAQ:TNOXTanox (MM)
17/12/200509:30PR Newswire (US)Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV TherapyNASDAQ:TNOXTanox (MM)
 Showing the most relevant articles for your search:NASDAQ:TNOX

Su Consulta Reciente

COIN
SOLUSD
Solana
COIN
BTCUSD
Bitcoin
FX
EURMXN
Euro vs MXN
NYSE
KO
Coca Cola
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
NYSE
BAC
Bank of America
NASDAQ
AMZN
Amazon.com
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
NVDA
NVIDIA
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados